NGL Fine-Chem Ltd
NGL Fine-Chem (BSE)

1,731.95

1,048.50
Proj. ROE (%)
-
Proj. P/E (x)
-
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
-

Stock View

-
Share on
The average score for NGL Fine-Chem Ltd stands at 4 against 6, three months back.

NGL Fine-Chem Limited is an India-based manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. The Company manufactures active pharmaceutical ingredients and finished formulations. Its products include APIs Animal Health, APIs Human Health, Intermediates and Finished Dosage Forms. The APIs Animal Health products include Homidium Chloride, Nitroxynil, Clorsulon, Parvaquone, Buparvaquone, Isometamidium Chloride Hydrochloride, Toldimfos Sodium, Butaphosphan, Imidocarb Dipropionate, Triclabendazole, Rafoxanide, Diminazene Aceturate, Diminazene Diaceturate and Decoquinate, among others. The APIs Human Health products include Nitazoxanide, Atovaquone and Ranolazine. The Intermediates products include 2-Chloro-N-(2,6-dimethylphenyl)acetamide, N-(2,6-Dimethylphenyl)-1-Piperazineacetamide and 2-[(2-methoxyphenoxy)methy]oxirane. The Finished dosage form products include Diminazene Aceturate Granules and Homidium Chloride Tablets.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
1,872.02
100 DMA ()
1,998.47
200 DMA ()
2,357.61
52 Weeks Range
1,599.85
3,789.45
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity